Adolore Biotherapeutics, Inc. | Finanzwire

Basculer en Français

9473	Companies
185399	Keywords
117755	Articles
99281	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

BRIEF

published on 02/04/2025 at 23:05, 10 months ago

Adolore BioTherapeutics to Present Gene Therapy Advancements at NANS 2025

Adolore BioTherapeutics Chronic Pain Gene Therapy Neurological Disorders NANS 2025
PRESS RELEASE

published on 02/04/2025 at 23:00, 10 months ago

Adolore BioTherapeutics to Present CA8* Neuromodulating Gene Therapy at the 2025 NANS Annual Meeting
Adolore BioTherapeutics to present CA8* chronic pain therapies and rdHSV delivery technology at 2025 NANS meeting. Company's focus on novel pain treatments highlighted

Adolore BioTherapeutics Neuromodulation CA8* Chronic Pain Therapies RdHSV Delivery Technology NANS
BRIEF

published on 10/02/2024 at 16:05, 1 year 2 months ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

Adolore BioTherapeutics Chronic Pain Treatments Opioid Alternatives 18th Annual Pain Therapeutics Summit CA8* Analgesic Peptides
PRESS RELEASE

published on 10/02/2024 at 16:00, 1 year 2 months ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology

Adolore BioTherapeutics Opioid-free Chronic Pain Treatments CA8 Peptides RdHSV Vectors
BRIEF

published on 09/24/2024 at 14:25, 1 year 2 months ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event

Adolore BioTherapeutics Chronic Pain Non-opioid Therapy BioSparkVA Roy C. Levitt
PRESS RELEASE

published on 09/24/2024 at 14:20, 1 year 2 months ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
Adolore BioTherapeutics to present innovative opioid-free chronic pain therapy at BioSpark Pitch Event. Programs for knee osteoarthritis & erythromelalgia in development

Adolore BioTherapeutics Chronic Pain Opioid-free Biotherapeutics Innovative Therapy
BRIEF

published on 07/30/2024 at 14:15, 1 year 4 months ago

Adolore BioTherapeutics Publishes Promising Preclinical Data on Non-Opioid Analgesic Gene Therapy

Adolore BioTherapeutics Chronic Pain Gene Therapy Osteoarthritis Non-opioid Analgesic
PRESS RELEASE

published on 07/30/2024 at 14:10, 1 year 4 months ago

Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Adolore BioTherapeutics validates a non-opioid analgesic gene therapy for chronic pain via local delivery to sensory neurons. Preclinical study supports opioid-free treatment for chronic knee pain due to OA

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesic Opioid-free Treatment
BRIEF

published on 06/10/2024 at 15:20, 1 year 5 months ago

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference

Adolore BioTherapeutics Opioid-free Gene Therapy Chronic Pain Treatment Virtual Investor Pitch Conference
PRESS RELEASE

published on 06/10/2024 at 15:15, 1 year 5 months ago

Adolore BioTherapeutics to Present at the Virtual Investor Pitch Conference
Adolore BioTherapeutics to present at Virtual Investor Pitch Conference on June 17, 2024, 10:00 AM ET. CEO Roelof Rongen to provide an elevator pitch on breakthrough opioid-free gene therapy treatments for chronic pain

Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy Virtual Investor Pitch Conference

Accesswire

Published on 12/05/2025 at 02:35, 6 hours 17 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 22 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 52 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 47 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 52 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:30, 22 minutes ago

Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 22 minutes ago

Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 47 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 51 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 51 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025

Les Echos

Published on 12/05/2025 at 08:45, 7 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 14 hours 52 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 7 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 8 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE